Cardinal Health Reports Strong First-Quarter Results For Fiscal 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call
November 4, 2015 3:03 PM ESTLeerink Partners reiterated an Outperform rating on Cardinal Health (NYSE: CAH), and raised the price target to $105.00 (from $100.00), following the company's 1Q16 earnings conference call. The strong 49bp increase in pharmaceutical segment operating margin (to 2.61%) was driven by generic strength. F2016 pharmaceutical segment revenue is now expected to be in the... More
UBS Raises Price target on Cardinal Health (CAH) Following 1Q16 Conference Call
November 3, 2015 8:36 AM ESTUBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More
Cardinal Health (CAH) Tops Q1 EPS by 28c
November 2, 2015 7:47 AM ESTCardinal Health (NYSE: CAH) reported Q1 EPS of $1.38, $0.28 better than the analyst estimate of $1.10. Revenue for the quarter came in at $28.1 billion versus the consensus estimate of $27.18 billion.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
... More